Bruker CORP Form 4 insider transactions

Director Bob Rosenthal reports acquiring 3,298 shares of Bruker Corp common stock through a grant of Restricted Stock Units (RSUs) that will vest on February 15, 2026.

Director Hermann Fritz Requardt acquired 3,298 shares of Bruker Corp common stock through a grant of Restricted Stock Units (RSUs) on February 15, 2025.

Director Adelene Q. Perkins reports acquisition of 3,298 shares of Bruker Corp common stock through restricted stock units.

Director Richard A. Packer reports acquisition of 3,298 shares of Bruker Corp common stock through restricted stock units.

Director John A Ornell reports acquisition of 3,298 shares of Bruker Corp common stock through Restricted Stock Units (RSUs).

Director William A. Linton acquired 3,298 shares of Bruker Corp common stock in the form of Restricted Stock Units (RSUs) on February 15, 2025.

Director Cynthia M. Friend reports changes in beneficial ownership of Bruker Corporation stock, including the acquisition of restricted stock units and disposal of shares.

Director Bonnie H. Anderson reports the acquisition of 3,298 Restricted Stock Units (RSUs) of Bruker Corp on February 15, 2025, which will vest on February 15, 2026.

Bruker Corporation's CEO, Frank H. Laukien, has recently acquired additional shares of the company's common stock through multiple transactions.

Richard A. Packer, a director at Bruker Corp, exercised stock options and sold a portion of the acquired shares on December 2, 2024.

Bruker Corp director William A. Linton exercised stock options to acquire 10,000 shares of common stock at a price of $19.12 per share.

Bruker Corporation's CEO, Frank H. Laukien, has acquired a total of 99,999 shares of common stock through multiple transactions on November 18, 2024.

Director Bob Rosenthal exercised stock options and sold shares of Bruker Corp on August 15, 2024.

Juergen Srega, President of CALID at Bruker Corporation, reports the acquisition of restricted stock units and stock options.

Bruker Corporation's CEO, Burkhard Prause, reports acquisition of stock options and restricted stock units.

Mark Munch, Executive VP & President of Bruker Nano Inc., reports acquisition of shares and stock options in Bruker Corporation.

Frank H. Laukien, CEO of Bruker Corp, reports acquisition of restricted stock units and stock options, as well as disposition of shares to cover tax obligations.

Executive Vice President and CFO of Bruker Corporation, Gerald N. Herman, reports acquisition of restricted stock units and stock options, as well as disposals to cover tax obligations.

Falko Busse, President of the BioSpin Group at Bruker Corp, reports the acquisition of stock options and vesting of restricted stock units (RSUs) on August 9, 2024.

Mark Munch, Executive VP & President of Bruker Nano Inc., disposed of shares to cover tax withholding obligations related to vesting restricted stock units.

Frank H. Laukien, President & CEO of Bruker Corp, reported disposing of shares to cover tax withholding obligations related to vesting restricted stock units.

Gerald N Herman, Executive Vice President and CFO of Bruker Corporation, reported disposing of shares to cover tax withholding obligations related to vesting restricted stock units.

Frank H Laukien, a director and President & CEO of Bruker Corp, reported disposing of 1,404 shares of common stock on December 16, 2023.

Director Hermann Fritz Requardt exercised stock options and sold Bruker Corp shares on March 4, 2024, according to a Form 4 filing.

Falko Busse, President of the BioSpin Group at Bruker Corp, exercised stock options and sold shares on February 28, 2024.